Drug application
DAPTOMYCIN (DAPTOMYCIN)
Drugs@FDA ANDA 206005 · XELLIA PHARMS APS
Key facts
| Drug name | DAPTOMYCIN |
|---|---|
| Active ingredients | DAPTOMYCIN |
| Application type | ANDA |
| Application number | 206005 |
| Company | XELLIA PHARMS APS |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | 500MG/VIAL |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jun 15, 2016 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.